top of page

About Us

Terasom is an innovative, cutting-edge biomedical startup, founded in September 2019, in Prague, Czech Republic. Our main focus is on developing novel exosome-based early lung cancer diagnostic and cancer therapy.​​

Did you 

know...

​2 in 3 lung cancer patients are diagnosed at a late metastastic stage, dwindling 5-year survival rates from 50% to 10%.  

This statistic is driven by the current high-cost, time-consuming diagnostic methods and the lack of specific lung cancer symptoms. As a consequence, only a small proportion of individuals with symptoms are diagnosed with lung cancer; therefore, widespread screening for lung cancer has not yet been adopted.

Nearly 1 in 5 cancer-related deaths is a result of lung cancer, with over 1.8 million deaths per year.  This is over double the deaths caused by bowel cancer, the next most deadly cancer.

image_edited.jpg

​In 2022, over 2.4 million people were diagnosed with lung cancer across the globe. 

Our Mission

At Terasom, we aim to provide an "All in One" platform to cover the 3 key pillars: "diagnose", "treat" and "regenerate", providing complex support for a patient's entire disease journey. 

Exosomes are tiny bioactive nanostructures containing thousands of proteins, lipids and nucleic acids. Their double bilayer membrane protects them from enzymatic degradation, thus giving them a longer lifespan than other floating biomolecules in the human body, and allowing them to cross over any physiogical barriers. These unique characteristics make them ideal for diagnostic, therapeutic and drug delivery purposes.

Click on the links below to find out more about each stage of our All-in-One platform!

pexels-karolina-grabowska-4226894.jpg

Diagnose

Diagnostics

Our novel set of specific lung cancer biomarkers, combined with our rapid detection technology uses a liquid biopsy, to enable the diagnosis of early or metastatic stages of lung cancer within only 15 minutes!

pexels-thirdman-7659689_edited.jpg

Treat

Immunotherapy Vaccine

Using the unique features of our bioengineered exosomes to overcome any physiological barriers, we have developed a new immunotherapy vaccine specifically for solid tumours, aiming to help patients recover from any stage of cancer.

pexels-yankrukov-8436740_edited.jpg

Regenerate

Regenarative medicine

We are developing a new regenerative medicine, using exosomes, to revitalise the deteriorated tissue within the patient’s damaged lungs and allow them to catch their breath.

Our Core Beliefs

We draw our values from Stoic philosophy, which emphasizes:

Self

Awareness

Rationality

Moral

Integrity

These principles serve as our Northern Star, helping us remain grounded, resilient, and ethically consistent in a complex and evolving industry frequently subject to disruption and uncertainty.

"What disturbs men's minds is not events but their judgements on events."

- Epictetus, Enchiridion

The principles are rooted in a commitment to the common good, acting with fairness and treating others justly. These values are not merely aspirational, but rather practical and actionable standards that inform and direct how we work, interact, and grow together.

bottom of page